Cheshmehnoor Pegah, Bolourchian Noushin, Abdollahizad Erfan, Derakhshi Arash, Dadashzadeh Simin, Haeri Azadeh
Department of Pharmaceutics and Pharmaceutical Nanotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Protein Technology Research Center, Shahid Beheshti University, Tehran, Iran.
Iran J Pharm Res. 2023 Feb 1;21(1):e130626. doi: 10.5812/ijpr-130626. eCollection 2022 Dec.
A large number of new substances have insufficient biopharmaceutical properties for oral administration caused by their slow dissolution rate and poor solubility.
The purpose of our experiment was to improve the physicochemical properties of a hydrophobic drug, quercetin, by the nanomilling approach.
Quercetin nanosuspensions were prepared using a wet-milling method followed by lyophilization. Stabilizer type and ratio, drug content, milling time, and bead size were identified as critical variables, and their impacts on quercetin particle size were assessed. The optimized nanocrystal was characterized by its morphology, crystallinity, molecular interactions, saturation solubility, and dissolution properties.
At optimized process conditions of milling at 500 rpm for 18 cycles of grinding with 0.3 - 0.4 mm zirconium oxide beads, minimum particle size, and PDI values were 281.21 nm and 0.22, respectively. Nanocrystals showed rod-like nanostructures, and XRD scans confirmed a decrease in drug crystallinity. The optimized formulation showed increased solubility and dissolution rate, as well as good physical stability.
Particle size reduction by media milling technique was an efficient method for the solubility enhancement of hydrophobic drugs.
大量新物质由于其溶解速度慢和溶解度差,口服时生物制药性能不足。
我们实验的目的是通过纳米研磨方法改善疏水性药物槲皮素的物理化学性质。
采用湿磨法制备槲皮素纳米混悬液,然后冻干。确定稳定剂类型和比例、药物含量、研磨时间和珠粒大小为关键变量,并评估它们对槲皮素粒径的影响。通过其形态、结晶度、分子相互作用、饱和溶解度和溶解性能对优化后的纳米晶体进行表征。
在优化的工艺条件下,以500 rpm的转速用0.3 - 0.4 mm的氧化锆珠研磨18个循环,最小粒径和PDI值分别为281.21 nm和0.22。纳米晶体呈现棒状纳米结构,XRD扫描证实药物结晶度降低。优化后的制剂显示出溶解度和溶解速率增加,以及良好的物理稳定性。
通过介质研磨技术减小粒径是提高疏水性药物溶解度的有效方法。